← Back to Search

Treatment for Age-Related Macular Degeneration

N/A
Waitlist Available
Led By Michael Elman, MD
Research Sponsored by Notal Vision Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5-10 minutes
Awards & highlights

Summary

this is a single In-Clinic Encounter With the Notal Vision Home OCT study. The study population will include up to 50 Age-related Macular Degeneration patients diagnosed with wet NV-AMD in at least one eye at the time of enrollment. All enrolled subjects should have at least one eye with active (wet) CNV (SRF and/or IRF) at the time of enrollment. All subjects will be enrolled at 1 site in the United States. in this study patients will be placed in a room with the Notal Vision Home OCT device and following a completion of a self tutorial will perform 3 unsupervised self-scans on each study eye (with a rest of \~5 minutes between self-scans). at the end of the testing sessions, the subject will be asked to complete subject user questionnaire.

Eligible Conditions
  • Age-Related Macular Degeneration

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5-10 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5-10 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percentage of eyes that performed 4 self-scans with the same fluid status
Percentage of subjects who completed self-scanning following a self-tutorial.
Summary of subject questionnaire results.

Find a Location

Who is running the clinical trial?

Notal Vision Inc.Lead Sponsor
8 Previous Clinical Trials
20,724 Total Patients Enrolled
Michael Elman, MDPrincipal InvestigatorMichael Elman, M.D. 9114 Philadelphia Rd #310 Baltimore, Maryland 21237
~14 spots leftby Sep 2025